We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amdocs Stock Rises 4% as Q1 Earnings and Revenues Surpass Estimates
Read MoreHide Full Article
Key Takeaways
Amdocs posted Q1 EPS of $1.81, topping estimates and rising 9% year over year.
Revenues grew 4.1% YOY to $1.156B and surpassed the consensus mark.
FY2026 outlook calls for 1.5-5.5% revenue growth and 4-8% EPS expansion.
Amdocs Limited (DOX - Free Report) shares gained 4% during Tuesday’s extended trading session after the company reported better-than-expected first-quarter fiscal 2026 results. DOX’s non-GAAP earnings of $1.81 per share came above the midpoint of management’s guidance of $1.73-$1.79 and increased 9% year over year. The figure also surpassed the Zacks Consensus Estimate of $1.75.
Amdocs’ first-quarter revenues of $1.156 billion topped the consensus mark of $1.15 billion and came above the midpoint of management’s $1.135-$1.175 million guidance range. The top line increased 4.1% on a reported basis and 3.5% on a constant-currency basis.
Amdocs’ Q1 Details
Amdocs reported a decline in revenues across North America, Europe and the Rest of the World (RoW). North America reported revenues of $765 million (66% of total revenues), which increased 3.7% year over year. Europe revenues (16% of total revenues) of $182 million soared 17% year over year.
RoW revenues (18% of total revenues) dropped 3.6% year over year to $209.5 million. Our model estimates for North America, RoW and Europe were pinned at $769.9 million, $209.2 million and $171.8 million, respectively.
Managed services revenues rose 2.3% year over year to $746 million. The company ended the first quarter of fiscal 2026 with a 12-month backlog of $4.25 billion, up $60 million sequentially. Our model estimates for managed services revenues and backlog were pegged at $760.6 million and $4.23 billion, respectively.
The non-GAAP operating income increased 6.2% year over year to $249.9 million, while the operating margin expanded 40 basis points (bps) to 21.6%.
Amdocs’ Balance Sheet & Cash Flow
Amdocs had cash and short-term investments of $247.9 million as of Dec. 31, 2025 compared with $325 million as of Sept. 30, 2025. Long-term debt was $647 million as of Dec. 31, 2025, almost flat to the Sept. 30, 2025 level of $646.9 million.
During the first quarter, it generated an operating cash flow of $220 million and a free cash flow of $188 million. During the first quarter, it repurchased shares worth $146.2 million and paid $57.2 million in dividends.
Amdocs Updates FY2026 & Q2 Guidance
For fiscal 2026, Amdocs now expects revenues to grow in the 1.5-5.5% range, instead of the earlier band of 1.7-5.7%. The Zacks Consensus Estimate for revenues is pegged at $4.7 billion, suggesting a year-over-year increase of 3.7%.
The non-GAAP operating margin is still anticipated to be in the range of 21.3-21.9% for fiscal 2026. Non-GAAP earnings per share are still expected to grow in the band of 4-8%. The Zacks Consensus Estimate for earnings is pegged at $7.42 per share, indicating a year-over-year rise of 6.2%.
The company still expects free cash flow between $710 million and $730 million.
Amdocs also initiated guidance for the second quarter of fiscal 2026. For the second quarter, the company expects revenues to be in the band of $1.15-$1.19 billion (midpoint $1.17 billion). The Zacks Consensus Estimate for revenues is pegged at $1.17 billion, suggesting a year-over-year jump of 3.4%.
Amdocs expects non-GAAP earnings per share to be between $1.73 and $1.79. The Zacks Consensus Estimate for earnings is pegged at $1.82 per share, calling for a year-over-year rise of 2.3%.
The Zacks Consensus Estimate for Amphenol’s 2026 earnings has been revised upward by 2 cents over the past seven days to $4.32 per share, calling for an increase of 29.3% year over year. Amphenol shares have surged 110.5% over the past year.
The Zacks Consensus Estimate for Micron Technology’s fiscal 2026 earnings has moved southward by 14 cents in the past 30 days to $32.90 per share, implying 296.9% year-over-year growth. Micron Technology shares have soared 362.1% over the past year.
The Zacks Consensus Estimate for Analog Devices’ fiscal 2026 earnings has moved northward by 21 cents over the past 30 days to $9.97 per share, indicating a year-over-year increase of 28%. Analog Devices shares have rallied 51.3% over the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Amdocs Stock Rises 4% as Q1 Earnings and Revenues Surpass Estimates
Key Takeaways
Amdocs Limited (DOX - Free Report) shares gained 4% during Tuesday’s extended trading session after the company reported better-than-expected first-quarter fiscal 2026 results. DOX’s non-GAAP earnings of $1.81 per share came above the midpoint of management’s guidance of $1.73-$1.79 and increased 9% year over year. The figure also surpassed the Zacks Consensus Estimate of $1.75.
Amdocs’ first-quarter revenues of $1.156 billion topped the consensus mark of $1.15 billion and came above the midpoint of management’s $1.135-$1.175 million guidance range. The top line increased 4.1% on a reported basis and 3.5% on a constant-currency basis.
Amdocs’ Q1 Details
Amdocs reported a decline in revenues across North America, Europe and the Rest of the World (RoW). North America reported revenues of $765 million (66% of total revenues), which increased 3.7% year over year. Europe revenues (16% of total revenues) of $182 million soared 17% year over year.
Amdocs Limited Price, Consensus and EPS Surprise
Amdocs Limited price-consensus-eps-surprise-chart | Amdocs Limited Quote
RoW revenues (18% of total revenues) dropped 3.6% year over year to $209.5 million. Our model estimates for North America, RoW and Europe were pinned at $769.9 million, $209.2 million and $171.8 million, respectively.
Managed services revenues rose 2.3% year over year to $746 million. The company ended the first quarter of fiscal 2026 with a 12-month backlog of $4.25 billion, up $60 million sequentially. Our model estimates for managed services revenues and backlog were pegged at $760.6 million and $4.23 billion, respectively.
The non-GAAP operating income increased 6.2% year over year to $249.9 million, while the operating margin expanded 40 basis points (bps) to 21.6%.
Amdocs’ Balance Sheet & Cash Flow
Amdocs had cash and short-term investments of $247.9 million as of Dec. 31, 2025 compared with $325 million as of Sept. 30, 2025. Long-term debt was $647 million as of Dec. 31, 2025, almost flat to the Sept. 30, 2025 level of $646.9 million.
During the first quarter, it generated an operating cash flow of $220 million and a free cash flow of $188 million. During the first quarter, it repurchased shares worth $146.2 million and paid $57.2 million in dividends.
Amdocs Updates FY2026 & Q2 Guidance
For fiscal 2026, Amdocs now expects revenues to grow in the 1.5-5.5% range, instead of the earlier band of 1.7-5.7%. The Zacks Consensus Estimate for revenues is pegged at $4.7 billion, suggesting a year-over-year increase of 3.7%.
The non-GAAP operating margin is still anticipated to be in the range of 21.3-21.9% for fiscal 2026. Non-GAAP earnings per share are still expected to grow in the band of 4-8%. The Zacks Consensus Estimate for earnings is pegged at $7.42 per share, indicating a year-over-year rise of 6.2%.
The company still expects free cash flow between $710 million and $730 million.
Amdocs also initiated guidance for the second quarter of fiscal 2026. For the second quarter, the company expects revenues to be in the band of $1.15-$1.19 billion (midpoint $1.17 billion). The Zacks Consensus Estimate for revenues is pegged at $1.17 billion, suggesting a year-over-year jump of 3.4%.
Amdocs expects non-GAAP earnings per share to be between $1.73 and $1.79. The Zacks Consensus Estimate for earnings is pegged at $1.82 per share, calling for a year-over-year rise of 2.3%.
DOX’s Zacks Rank and Stocks to Consider
Currently, Amdocs carries a Zacks Rank #4 (Sell).
Amphenol (APH - Free Report) , Micron Technology (MU - Free Report) and Analog Devices (ADI - Free Report) are some other top-ranked stocks that investors can consider in the Zacks Computer and Technology sector. Amphenol and Micron Technology sport a Zacks Rank #1 (Strong Buy) each at present, while Analog Devices carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Amphenol’s 2026 earnings has been revised upward by 2 cents over the past seven days to $4.32 per share, calling for an increase of 29.3% year over year. Amphenol shares have surged 110.5% over the past year.
The Zacks Consensus Estimate for Micron Technology’s fiscal 2026 earnings has moved southward by 14 cents in the past 30 days to $32.90 per share, implying 296.9% year-over-year growth. Micron Technology shares have soared 362.1% over the past year.
The Zacks Consensus Estimate for Analog Devices’ fiscal 2026 earnings has moved northward by 21 cents over the past 30 days to $9.97 per share, indicating a year-over-year increase of 28%. Analog Devices shares have rallied 51.3% over the past year.